BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8729209)

  • 1. Rifabutin versus placebo in combination with three drugs in the treatment of nontuberculous mycobacterial infection in patients with AIDS.
    Dautzenberg B; Olliaro P; Ruf B; Esposito R; Opravil M; Hoy JF; Rozenbaum W; Carosi GP; Micoud M; L'Age M; Pirotta N; Sassella D
    Clin Infect Dis; 1996 Apr; 22(4):705-8. PubMed ID: 8729209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of nontuberculous mycobacterial infections in pediatric patients.
    Levin RH; Bolinger AM
    Clin Pharm; 1988 Jul; 7(7):545-51. PubMed ID: 2843317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunist mycobacteria. Groupe d'Etude et de Traitement des Infections à Mycobacteries Résistantes.
    Dautzenberg B; Truffot C; Mignon A; Rozenbaum W; Katlama C; Perronne C; Parrot R; Grosset J
    Tubercle; 1991 Sep; 72(3):168-75. PubMed ID: 1663282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. The Rifabutin Treatment Group.
    Sullam PM; Gordin FM; Wynne BA
    Clin Infect Dis; 1994 Jul; 19(1):84-6. PubMed ID: 7948562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of the body burden of M. avium complex is associated with improved quality of life and prolonged survival of patients with AIDS: a prospective trial with rifabutin combined with isoniazid, clofazimine, ethambutol.
    Olliaro P; Dautzenberg B
    J Chemother; 1994 Jun; 6(3):189-96. PubMed ID: 7983502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of rifabutin in Europe for the treatment of mycobacterial infection in AIDS patients.
    Dautzenberg B
    Infection; 1997; 25(1):63-6. PubMed ID: 9039546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.
    Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR
    Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with rifabutin in the treatment of mycobacterial infections.
    De Cian W; Sassella D; Wynne BA
    Scand J Infect Dis Suppl; 1995; 98():22-6. PubMed ID: 8867175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early bactericidal activity of rifabutin versus that of placebo in treatment of disseminated Mycobacterium avium complex bacteremia in AIDS patients.
    Dautzenberg B; Castellani P; Pellegrin JL; Vittecoq D; Truffot-Pernot C; Pirotta N; Sassella D
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1722-5. PubMed ID: 8807071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
    Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR
    Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome.
    Benson CA; Williams PL; Currier JS; Holland F; Mahon LF; MacGregor RR; Inderlied CB; Flexner C; Neidig J; Chaisson R; Notario GF; Hafner R;
    Clin Infect Dis; 2003 Nov; 37(9):1234-43. PubMed ID: 14557969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients.
    Hoy J; Mijch A; Sandland M; Grayson L; Lucas R; Dwyer B
    J Infect Dis; 1990 Apr; 161(4):801-5. PubMed ID: 2156947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of triple drug regimen of amikacin, ethambutol and rifabutin in AIDS patients with symptomatic Mycobacterium avium complex infection.
    Jorup-Rönström C; Julander I; Petrini B
    J Infect; 1993 Jan; 26(1):67-70. PubMed ID: 8384230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress report: prophylaxis and therapy for MAC.
    Currier J
    AIDS Clin Care; 1996 Jun; 8(6):45-8. PubMed ID: 11363599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
    Fisher M; Tomlinson DR; Coker RJ
    Int J STD AIDS; 1996 Jul; 7(4):244-9; quiz 249-51. PubMed ID: 8876354
    [No Abstract]   [Full Text] [Related]  

  • 18. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV.
    Uthman MM; Uthman OA; Yahaya I
    Cochrane Database Syst Rev; 2013 Apr; (4):CD007191. PubMed ID: 23633339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Talbot JA; Chomyc S; Davison E; Singer J; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG
    Clin Infect Dis; 1998 Dec; 27(6):1401-5. PubMed ID: 9868650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients.
    Ruf B; Schürmann D; Mauch H; Jautzke G; Fehrenbach FJ; Pohle HD
    Infection; 1992; 20(5):267-72. PubMed ID: 1428183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.